# Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers

> **NCT02245204** · PHASE1 · COMPLETED · sponsor: **Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd** · enrollment: 8 (actual)

## Conditions studied

- Advanced Cancer

## Interventions

- **DRUG:** Chlorogenic acid

## Key facts

- **NCT ID:** NCT02245204
- **Lead sponsor:** Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2018-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02245204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02245204, "Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02245204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*